Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OWCP is the chance of a lifetime. This company has done everything it said it would. A stock investor invested in OWCP has been to the office in Israel, talked in depth with management, and tried the prototype cream. It's all real. He sent me the photos he took. He also visited the hospital where they are doing the clinical trials and talked to many people and all had great thing to say about OWCP.
There are extremely well positioned and experienced people on the OWCP team.
Dr. Med. Yehuda Baruch, Director of Research and Regulatory Affairs – One World Cannabis Ltd. Dr. Baruch served as Head of the Israeli Ministry of Health’s Medical Marijuana Program from 2003 through 2013 where he spearheaded the efforts on regulation, chaired the indication committee, secured Helsinki Approvals for medical research, and managed regulation of patient licensing and dosage. He has extensive experience in researching medical cannabis, most notably for its effect on PTSD.
From 2004 until recently he served as CEO of Abarbanel Mental Health Center in Bat Yam, Israel. Prior to that, he was the director of Israel’s Ministry of Health medical management division, and director general of Be’er Yakov Mental Health Center. He has taught at Ben-Gurion University of the Negev and Tel Aviv University’s Sackler School of Medicine.
~~~~~~~~
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Sharon Rozenblat as Senior Advisor to the Scientific Advisory Board of its wholly-owned Israeli subsidiary, One World Cannabis Ltd ("OWC Israel").
~~~~~~~~~
DR. SHARON ROZENBLAT, PH.D. is an independent consultant in the field of herbal research and product development for the cosmetics, pharma and raw materials industries. She has over 15 years’ experience in research and development of herbal extracts and products, mainly in the field of dermatology. In the past 8 years, Dr. Rozenblat served as the chief scientist at Kamedis ltd. in Israel, an herbal-based dermatological company, where she had established the R&D department and led the herbal research and the development of herbal-based products for the treatment of different dermatological conditions. She also served as the scientific research director of joint development projects funded by the Korea-Israel Industrial R&D Foundation (KORIL) and Israel-Singapore foundation (SIIRD) resulting in numerous products and patents. In her work in Chengdu, China, she had developed advanced extraction methods and Quality Control methodology. Dr. Rozenblat gives lectures in many dermatology and biotechnology conferences. Dr. Rozenblat earned her doctorate in Biochemistry and Cell Biology from Bar Ilan University in Israel, where her research focused on botanical components as therapeutic agents for melanoma.
Dr. Yehuda Baruch, OWC's Chief Scientific Officer, commented on the appointment, "Dr. Rozenblat has had a significant impact in the field of dermatology, specifically with regard to botanical formulations. With more than 15 years' experience in the research and development of herbal extracts and related products, as well as considerable experience in the design and management of clinical trials, she is the perfect complement to our scientific team."
From 2007 to 2015, Dr. Rozenblat served as Chief Scientist at Kamedis ltd., an Israeli-based dermatological company, where she had established and managed the research and development of herbal products for the treatment of dermatological conditions.
In addition to her work at Kamedis, Dr. Rozenblat serves as a consultant to international organizations, including as Scientific Research Director of joint development projects funded by the Korea-Israel Industrial Research and Development Foundation (KORIL), and the Israel-Singapore Foundation (SIIRD), both of which resulted in numerous products and patents. Dr. Rozenblat was also the Scientific Director for the development of herbal extraction in a joint venture with Green Mountain Biotech (GMB), in Chengdu, China, where she worked with GMB to find agricultural resources, develop extraction methods, establish quality control methodologies, and conduct safety and efficacy studies.
Do your own DD. This company has an awesome leadership team with cutting edge experience in this space.
http://www.iccm.org.il/en/dr-sharon-rozenblat-ph-d/
http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-appoints-dr-sharon-rozenblat-senior-advisor-to-scientific-advisory-board-of-its-wholly-owned-subsidiary-613002483.html
Yes that was a very positive 8K which means yet another expert in this field is on the OWCP team.
Dr. Rozenblat has over 15 years of experience in research and development of the study and application of herbal extracts for medical products mainly in the field of dermatology. From 2007 through 2015, Dr. Rozenblat served as the Chief Scientist at Kamedis Ltd., located in Tel Aviv-Yafo, Israel, an herbal-based dermatological company that was founded in 1998 for development of products to treat skin conditions. As the Chief Scientist, Dr. Rozenblat was also Director of Kamedis' R&D Department, integrating traditional herbal knowledge with advanced pharmacology for the development of herbal-based products for the treatment of a variety of human dermatological conditions.
An email sent OWCP management the following email in reply from OWCP seems to support the clinical trial listed on clinicaltrials.gov is the same safety study as the one being done by the IRB in Israel:
--------------------------------------------------------------------------
March 11, 2017, 10:54 PM
Hello, online I came across this study:
https://clinicaltrials.gov/ct2/show/results/NCT02976779
Am I correct to assume that this is a different study than the one currently being conducted? My question was and still is: Considering the study was to have begun in February and it was expected to be completed in July 2017, however on this site it states: "this study is not yet open for participant recruitment", so why has it not begun yet and what is it's current status?
Please clarify.
Thank you,
--------------------------------------------------------------------------
I received the following reply from owcp@owcpharma.com and it was also ccd to Alon Sinai and Jeff Smurlick:
March 12, 2017, 12:21 PM
Hi . First , thanks for the support
Second , Just to be accurate :
The company did not announce the start of the study on February .
We announced that we received IRB approval to conduct the study.
The link :https://clinicaltrials.gov/ct2/show/results/NCT02976779
It is a federal link and might not be up to date.
After we received the approval , together with the hospital we recruited all the patients which mean the study is not open for free volunteers and , I guess , this what the link means .
IMHO the 10K will be solid and make the PPS take off again. Don't get left behind.
$OWCP
Dr. Sharon Rozenblat, Senior Advisor to the Scientific Advisory Board, will be tasked with overseeing the completion of the pre-clinical safety studies on the Company's treatment for psoriasis, which commenced in November 2016. Dr. Rozenblat will also steer the Company's efforts to commercialize OWC's cannabis-based formulations and delivery mechanisms.
Dr. Yehuda Baruch, OWC's Chief Scientific Officer, commented on the appointment, "Dr. Rozenblat has had a significant impact in the field of dermatology, specifically with regard to botanical formulations. With more than 15 years' experience in the research and development of herbal extracts and related products, as well as considerable experience in the design and management of clinical trials, she is the perfect complement to our scientific team."
From 2007 to 2015, Dr. Rozenblat served as Chief Scientist at Kamedis ltd., an Israeli-based dermatological company, where she had established and managed the research and development of herbal products for the treatment of dermatological conditions.
In addition to her work at Kamedis, Dr. Rozenblat serves as a consultant to international organizations, including as Scientific Research Director of joint development projects funded by the Korea-Israel Industrial Research and Development Foundation (KORIL), and the Israel-Singapore Foundation (SIIRD), both of which resulted in numerous products and patents. Dr. Rozenblat was also the Scientific Director for the development of herbal extraction in a joint venture with Green Mountain Biotech (GMB), in Chengdu, China, where she worked with GMB to find agricultural resources, develop extraction methods, establish quality control methodologies, and conduct safety and efficacy studies.
http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-appoints-dr-sharon-rozenblat-senior-advisor-to-scientific-advisory-board-of-its-wholly-owned-subsidiary-613002483.html
Keep in mind that TEVA made an offer to One World Cannabis (OWC) to purchase the rights to the company’s patents.
http://www.jewishpress.com/news/breaking-news/teva-pharmaceuticals-thinks-its-high-time-for-medical-marijuana/2015/07/21/
Con you please post some replies to those posts so we can read them?
True story: back in the 80's and 90's I used to have really dry skin on the bottom of my feet and deep cracks developed. I tried to address it for years using many different skin moisturizers but the deep cracks persisted and some of them were even a little painful. One day I was walking through a mall and saw the Body Shop and just went in to browse and check out this store I had never noticed before. I came across their hemp section and saw a couple products that interested me. One product was "Hemp Butter" and it was in a round flat tin with a lid that screwed on and off. After talking to one of their salespersons I decided to spend the $20 and buy one. The color of the paste was a medium green and it smelled like hemp oil. After using it for a little while I noticed the cracks starting to become shallower (less deep), so I used it more regularly and eventually the cracks in the bottom of my feet filled in completely.
That was a long time ago; I found a product that looks similar but I have no idea if they have changed the formula. The one I bought and then bought more of and had on hand for a couple years was in a metal tin.
http://www.ulta.com/hemp-body-butter?productId=xlsImpprod4181175&sku=2243415&cmpid=PS_Non!google!Product_Listing_Ads&cagpspn=pla&CATCI=pla-18283950120&CAAGID=18002902230&CAWELAID=1238871261&catargetid=330000200000190441&cadevice=c&gclid=CKfd7bK9p9MCFRc9gQodEFwAFA
My point is that if hemp seed oil can do what that stuff did for me, then I'm certain that the skin cream OWCP is working on using all the beneficial properties of the Cannabis plant can alleviate skin issues like they are claiming. From my own experience the Cannabis plant has amazing medicinal properties and OWCP has a knowledge base of research going back over ten years of medicinal possibilities of Cannabis.
This company is going to make long investors a lot of money.
$ OWCP long and strong $
Good Post.
Something to keep in mind over the weekend. OWCP made an agreement with Medmar LLC (a company in Maryland with political ties) for an investment of $300,000 interest free to be paid back by royalties of sales. In exchange Medmar gets to produce and market the cream within the United States. Steve Weinstein is the CEO of Medmar, and after doing his own DD of OWCP decided to make the $300,000 investment.
Mr. Weinstein went on to say, "We learned about OWC as they are one of only a handful of companies taking a true clinical approach to the research and development of medical cannabis, and this was important to us. Once we saw the preliminary results for their clinical studies, particularly in the field of psoriasis, we decided to make an investment and partner with them."
None of this has changed. The psoriasis cream test has moved forward with 70% efficacy results and on-the-market forecast by Q3.
OWCP is going to go up big once the psoriasis cream is on the market in the US or anywhere in the world.
Do your own DD
http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-signs-agreement-with-us-partner-for-funding-in-advance-of-future-royalties-595393011.html
LOCK UP YOUR SHARES before Monday by placing them for SELL @ $4+
This way the MMs can't loan them out for shorts to borrow and make them cover!
I agree. "Due on the business day after the 10-K due date."
FYI - from a post on Monday or Tuesday someone had emailed the company and they replied that it was pass over and would be back at the office on Wed April 12th.
According to google:
Passover 2017 in Israel began in the evening of
Monday, April 10
and ends in the evening of
Monday, April 17
How did the company pump the stock?
It's time to get in from the sideline before a solid 10k is release Monday morning.
Man they are trying hard as hell to bring down the PPS
10K will most likely be in line an we may get a little EOD rally. Anticipation is still in play and if there is nothing wrong with the 10K then folks will get in on Monday.
It's a small company increasing it's sales of diapers. Selling them on Amazon is a no-brainer. How do you know the reviews on amazon are fake? Why would you say Taiwo Aimasiko should stop selling thru Amazon? It comes across that you think this is just another pump and dump scam.
Did you ever consider that she actually wants to sell diapers???
In barely looking at this company I instantly got the impression that the sales are in a beginning phase and Taiwo Aimasiko plans on selling diapers through multiple distribution channels including wholesalers. Why would a low ranking on Amazon cause an investor to think that these diapers are not as popular as brand name diapers when any and every investor would already be thinking that?
In another one of your post you say that the Bemax diapers suck because they're made in China.
First, everything is made in China EXCEPT:
"Bemax private label brands for U.S market are made in the U.S. Thanks for your interest.
By Baby Diapers Bemax Brands SELLER on April 6, 2017"
second, have you actually held the diaper and examined it's quality?
third, the true test of how well they work is when the baby makes a mess in the diaper. Have you tested the diaper on a live human baby to see how well it works in action?
Thanks for another good link to a positive article about OWCP, I appreciate it.
https://psoriasisnewstoday.com/2017/04/11/owc-cannabinoid-based-topical-cream-psoriasis/
If you read all the way to the bottom then you would see the disclosure:
"Disclosure: We have no position in OWCP or GWPH and have not been compensated for this article."
Hey I-Glow, is this bogus or what? They're actually doing the clinical trials???
Good post mistafixit:
https://clinicaltrials.gov/ct2/show/NCT02976779?term=owc&rank=1
HOT DAMN! I can't wait until it hits $5 by the end of April.
me: hmmm?
Broken Record: no patents, NOT ONE!
some other dude: IG you don't know what your talking about. They have provisional patents...it's a process.
Broken Record: no patents, it's just not true. I know what I'm talking about.
some dude: Well you don't have your facts straight and you don't know what you're talking about.
Broken Record: This is the same sh#t different day bla bla bla... also THEY HAVE NO PATENTS!!!!!!!
some other dude: I interviewed the lawyer who handles the OWCP patents. Here IG take a look
---------------> look here, a link, super easy <----------------------
Broken Record: hunh? what? by the way did I mention that THEY HAVE NO PATENTS???!!!?!???!!1!!!!
some totally other dude: WTF
seriously though:
http://ownthefloat.com/index.php/2017/04/12/owcp-the-truth-about-the-patent-process/
Damn! Every time Camelot shows up this stock gets wonky.
any updates on when this ETF will launch?
https://www.newcannabisventures.com/first-cannabis-etf-in-the-works-emerging-agrosphere/
You got mentioned Mr. broken record.
http://ownthefloat.com/index.php/2017/04/12/owcp-the-truth-about-the-patent-process/
Remember to screenshot this Chart.
Can anyone explain why Mordechai Bignitz the CEO does not own any shares while all of the other management do?
Feels good to see us in the green today.
Thanks for the feedback. I just read an article about it and he claims she wasn't his patient and it was a consensual relationship. Any recent statements made about any ongoing investigation? How do you know he's still being investigated?
thanks for the feedback
"People like this don't risk their lives reputation to make a scam out of their dreams."
I agree. Good post
Well thanks for the reply. I hope they are actually going to make this product this year. If they were outright lying and not planning on doing so, I would think that the word would get out about such outrageous fraud with OWCP that they wouldn't be trusted in the next venture. Just seems like a lot of analyst have been watching this stock and if they failed to actually produce the cream product that their reputations would seriously suffer.
However I am an amateur and maybe my perspective isn't realistic and frauds like that happen all the time. IMHO that would be a bold fraud if they create no product.
As of 2 or 3 days ago Ziv is no longer on the OWCPharma website.
http://www.owcpharma.com/our-leadership-team/
That was when I starting trying to figure out why and all I have been able to find is chatter.
But why would he be removed from their management page on their website?
Does anyone know for sure what the filing rules are on the OTC for such a management change?
I hear what you're saying. Do you think they are lying about their plans to develop and bring to market this cream and the tablets?
I never knew much about Ziv. But after the run and subsequent fall it seemed like exposure for OWCP just went flat and I remember thinking why aren't they promoting it better? I certainly couldn't do that job. Hopefully they get someone very qualified for the job who gets after it.
That's where I was coming from. Ziv is probably a nice guy, just didn't seem to show us what he was doing as far as gaining more exposure and interest... I expected more if I'm going to be honest.
He sure didn't do much to promote OWCP since the conference in Miami. I hope the others have realized what kind of star they need in that position and get that person on the team. If they do that quickly then yes the Ziv changeout could be the change we needed.